620017 - Kymera Therapeutics: Building a Biotech Execution Plan

Status

Published

on 12 May 2020

Year of Creation

2019

President and Fellows of Harvard College

Registration Number

TX0008875822

on 12 May 2020

The U.S. Copyright record (Registration Number: TX0008875822) dated 12 May 2020, pertains to an electronic file (eService) titled "620017 - Kymera Therapeutics: Building a Biotech Execution Plan" created in 2019. The copyright holder is President and Fellows of Harvard College, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to President and Fellows of Harvard College.

President and Fellows of Harvard College

Application Details

Registration Number

TX0008875822

Registration Date

5/12/2020

Year of Creation

2019

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

President and Fellows of Harvard College

Physical Description

Print material

First Publication Nation

United States

Corporate Authors

President and Fellows of Harvard College

Notes

Rights Note: Harvard Business Publishing, 20 Guest Street, Suite 700, Brighton, MA, 02135, United States, permissions2@hbsp.harvard.edu

Statements

Application Title Statement: 620017 - Kymera Therapeutics: Building a Biotech Execution Plan

Author Statement: President and Fellows of Harvard College employer for hire Domicile: United States Citizenship: United States Authorship: text

Notes

Rights Note: Harvard Business Publishing, 20 Guest Street, Suite 700, Brighton, MA, 02135, United States, permissions2@hbsp.harvard.edu

Statements

Application Title Statement: 620017 - Kymera Therapeutics: Building a Biotech Execution Plan

Author Statement: President and Fellows of Harvard College employer for hire Domicile: United States Citizenship: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.